MedTrace Logo

Use of Hyoscyamine Versus Tamsulosin for Management of Ureteral Stent Irritation

NCT03750656 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2024-12-03

Study results available
· View outcomes & findings →

Summary

The objective of this project is to compare the efficacy of hyoscyamine to tamsulosin monotherapy in treating lower urinary tract symptoms in patients with indwelling double-J ureteral stents.

Conditions

  • Lower Urinary Tract Symptoms

Interventions

DRUG

Hyoscyamine

Patients will be randomized to receive hyoscyamine for lower urinary tract symptoms are placement of ureteral stent

DRUG

Tamsulosin

Patients will be randomized to receive tamsulosin for lower urinary tract symptoms are placement of ureteral stent

Sponsors & Collaborators

  • University of Kansas Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-12
Primary Completion
2020-08-31
Completion
2020-08-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03750656 on ClinicalTrials.gov